Neuvivo Adds Former FDA Chief Counsel Peter Barton Hutt as Advisor

PALO ALTO, Calif., June 20, 2022 /PRNewswire/ -- Neuvivo, a private late-clinical stage company developing an effective treatment for ALS and other neurodegenerative diseases, today announced it has added Peter Barton Hutt as advisor. Peter is senior counsel in the Washington, DC law firm...

Click to view original post